As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
-
-
Identification of serum biomarker panel to differentiate malignant from benign thyroid nodules using multiplex bead assay
-
Impact of DAXX and ATRX expression on telomere length and prognosis of breast cancer patients
-
Localized Wilms’ tumor in low-middle-income countries (LMIC): how can we get better?
-
Initial absolute monocyte count as an immune biomarker for clinical response in acute myeloid leukemia with monocytic differentiation
-
Primary desmoplastic small-round-cell tumor of the ovary
-
Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center
-
Vulvar cancer: surgical management and survival trends in a low resource setting
-
Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial
-
Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview
About the Editor
Heba Moussa, MD.
Department of Clinical Pathology, National Cancer Institute, Cairo University, Egypt.
Aims and scope
As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.
About the Society
Journal of the Egyptian National Cancer Institute is the official journal of the National Cancer Institute, Cairo University, accomplishing high quality research in its respected field.
Official journal of
-
Journal of the Egyptian National Cancer Institute is the official journal of the National Cancer Institute, Egypt.
Citation Impact
0.94 - CiteScore
0.541 - SNIP (Source-Normalized Impact per Paper)
0.334 - SJR (SCImago Journal Rank)
- ISSN: 2589-0409 (electronic)
